Biomerica, Inc. (BMRA)
USD 0.51
(-4.89%)
USD 0.51
(-4.89%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 5.41 Million USD | 1.42% |
| 2023 | 5.33 Million USD | -71.71% |
| 2022 | 18.87 Million USD | 162.14% |
| 2021 | 7.19 Million USD | 7.57% |
| 2020 | 6.69 Million USD | 28.69% |
| 2019 | 5.2 Million USD | -6.53% |
| 2018 | 5.56 Million USD | -3.93% |
| 2017 | 5.79 Million USD | 12.68% |
| 2016 | 5.13 Million USD | 3.58% |
| 2015 | 4.96 Million USD | -3.09% |
| 2014 | 5.12 Million USD | -20.89% |
| 2013 | 6.47 Million USD | 6.44% |
| 2012 | 6.08 Million USD | 24.12% |
| 2011 | 4.89 Million USD | -3.46% |
| 2010 | 5.07 Million USD | 2.85% |
| 2009 | 4.93 Million USD | 0.17% |
| 2008 | 4.92 Million USD | -14.3% |
| 2007 | 5.74 Million USD | -20.0% |
| 2006 | 7.18 Million USD | -22.53% |
| 2005 | 9.27 Million USD | 1.15% |
| 2004 | 9.16 Million USD | 1.2% |
| 2003 | 9.05 Million USD | 5.37% |
| 2002 | 8.59 Million USD | -3.82% |
| 2001 | 8.93 Million USD | 11.28% |
| 2000 | 8.03 Million USD | -7.66% |
| 1999 | 8.7 Million USD | -7.45% |
| 1998 | 9.4 Million USD | 2.17% |
| 1997 | 9.2 Million USD | -3.16% |
| 1996 | 9.5 Million USD | 3.26% |
| 1995 | 9.2 Million USD | 10.84% |
| 1994 | 8.3 Million USD | 3.75% |
| 1993 | 8 Million USD | 2.56% |
| 1992 | 7.8 Million USD | -25.0% |
| 1991 | 10.4 Million USD | 26.83% |
| 1990 | 8.2 Million USD | 583.33% |
| 1989 | 1.2 Million USD | -14.29% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.56 Million USD | -8.52% |
| 2024 Q1 | 1.71 Million USD | 54.57% |
| 2024 Q4 | 1.11 Million USD | 9.73% |
| 2024 Q3 | 1.01 Million USD | -35.1% |
| 2024 FY | 5.41 Million USD | 1.42% |
| 2023 FY | 5.33 Million USD | -71.71% |
| 2023 Q3 | 1.11 Million USD | -25.0% |
| 2023 Q1 | 1.63 Million USD | -69.12% |
| 2023 Q2 | 1.48 Million USD | -9.5% |
| 2023 Q4 | 1.1 Million USD | -0.29% |
| 2022 Q4 | 5.3 Million USD | -30.78% |
| 2022 Q1 | 1.26 Million USD | 19.71% |
| 2022 Q2 | 4.64 Million USD | 268.28% |
| 2022 Q3 | 7.66 Million USD | 64.85% |
| 2022 FY | 18.87 Million USD | 162.14% |
| 2021 FY | 7.19 Million USD | 7.57% |
| 2021 Q1 | 1.14 Million USD | -58.03% |
| 2021 Q3 | 3.62 Million USD | 164.38% |
| 2021 Q2 | 1.37 Million USD | 20.0% |
| 2021 Q4 | 1.05 Million USD | -70.95% |
| 2020 Q1 | 1.19 Million USD | 2.45% |
| 2020 Q3 | 1.17 Million USD | -26.28% |
| 2020 Q2 | 1.59 Million USD | 33.66% |
| 2020 FY | 6.69 Million USD | 28.69% |
| 2020 Q4 | 2.72 Million USD | 131.54% |
| 2019 Q1 | 1.27 Million USD | 12.6% |
| 2019 Q2 | 1.5 Million USD | 17.91% |
| 2019 Q3 | 1.26 Million USD | -15.97% |
| 2019 Q4 | 1.16 Million USD | -7.56% |
| 2019 FY | 5.2 Million USD | -6.53% |
| 2018 Q2 | 1.61 Million USD | 11.71% |
| 2018 Q1 | 1.44 Million USD | -0.34% |
| 2018 Q3 | 1.37 Million USD | -14.75% |
| 2018 FY | 5.56 Million USD | -3.93% |
| 2018 Q4 | 1.13 Million USD | -17.83% |
| 2017 Q4 | 1.44 Million USD | -3.37% |
| 2017 Q1 | 1.41 Million USD | 6.33% |
| 2017 FY | 5.79 Million USD | 12.68% |
| 2017 Q2 | 1.43 Million USD | 1.57% |
| 2017 Q3 | 1.49 Million USD | 4.73% |
| 2016 Q2 | 1.16 Million USD | -9.47% |
| 2016 Q4 | 1.32 Million USD | -2.61% |
| 2016 Q1 | 1.28 Million USD | -13.91% |
| 2016 FY | 5.13 Million USD | 3.58% |
| 2016 Q3 | 1.36 Million USD | 16.87% |
| 2015 FY | 4.96 Million USD | -3.09% |
| 2015 Q3 | 1.29 Million USD | 14.63% |
| 2015 Q4 | 1.49 Million USD | 15.05% |
| 2015 Q1 | 1.03 Million USD | -38.39% |
| 2015 Q2 | 1.13 Million USD | 9.58% |
| 2014 Q1 | 1.01 Million USD | -31.06% |
| 2014 FY | 5.12 Million USD | -20.89% |
| 2014 Q3 | 1.49 Million USD | 59.68% |
| 2014 Q2 | 934.84 Thousand USD | -7.78% |
| 2014 Q4 | 1.67 Million USD | 12.49% |
| 2013 FY | 6.47 Million USD | 6.44% |
| 2013 Q4 | 1.47 Million USD | 3.8% |
| 2013 Q3 | 1.41 Million USD | -24.79% |
| 2013 Q2 | 1.88 Million USD | 10.68% |
| 2013 Q1 | 1.7 Million USD | 10.36% |
| 2012 Q2 | 1.61 Million USD | 14.84% |
| 2012 Q3 | 1.51 Million USD | -6.31% |
| 2012 Q4 | 1.54 Million USD | 1.82% |
| 2012 Q1 | 1.4 Million USD | 15.86% |
| 2012 FY | 6.08 Million USD | 24.12% |
| 2011 FY | 4.89 Million USD | -3.46% |
| 2011 Q3 | 1.34 Million USD | 15.94% |
| 2011 Q1 | 1.17 Million USD | -15.71% |
| 2011 Q2 | 1.16 Million USD | -1.43% |
| 2011 Q4 | 1.21 Million USD | -9.73% |
| 2010 Q4 | 1.39 Million USD | -2.28% |
| 2010 Q2 | 1.09 Million USD | -4.24% |
| 2010 FY | 5.07 Million USD | 2.85% |
| 2010 Q1 | 1.14 Million USD | -7.84% |
| 2010 Q3 | 1.42 Million USD | 29.98% |
| 2009 Q3 | 1.37 Million USD | 22.58% |
| 2009 Q4 | 1.24 Million USD | -9.27% |
| 2009 Q1 | 1.19 Million USD | -9.39% |
| 2009 Q2 | 1.12 Million USD | -6.18% |
| 2009 FY | 4.93 Million USD | 0.17% |
| 2008 Q4 | 1.31 Million USD | 6.23% |
| 2008 FY | 4.92 Million USD | -14.3% |
| 2008 Q2 | 1.02 Million USD | -23.32% |
| 2008 Q1 | 1.34 Million USD | -31.32% |
| 2008 Q3 | 1.24 Million USD | 20.76% |
| 2007 Q3 | 1.31 Million USD | -1.54% |
| 2007 Q1 | 1.15 Million USD | -21.43% |
| 2007 FY | 5.74 Million USD | -20.0% |
| 2007 Q4 | 1.95 Million USD | 48.77% |
| 2007 Q2 | 1.33 Million USD | 15.51% |
| 2006 Q3 | 998.07 Thousand USD | -58.36% |
| 2006 Q2 | 2.39 Million USD | 3.23% |
| 2006 Q1 | 2.32 Million USD | -10.08% |
| 2006 FY | 7.18 Million USD | -22.53% |
| 2006 Q4 | 1.46 Million USD | 47.06% |
| 2005 Q3 | 2.34 Million USD | 8.42% |
| 2005 FY | 9.27 Million USD | 1.15% |
| 2005 Q2 | 2.16 Million USD | -1.0% |
| 2005 Q1 | 2.18 Million USD | -3.76% |
| 2005 Q4 | 2.58 Million USD | 10.15% |
| 2004 Q3 | 2.46 Million USD | 8.59% |
| 2004 Q1 | 2.16 Million USD | -14.87% |
| 2004 FY | 9.16 Million USD | 1.2% |
| 2004 Q4 | 2.26 Million USD | -7.92% |
| 2004 Q2 | 2.26 Million USD | 4.87% |
| 2003 Q1 | 2.08 Million USD | 0.08% |
| 2003 FY | 9.05 Million USD | 5.37% |
| 2003 Q4 | 2.54 Million USD | 10.96% |
| 2003 Q3 | 2.29 Million USD | 7.25% |
| 2003 Q2 | 2.13 Million USD | 2.25% |
| 2002 Q3 | 2.31 Million USD | 4.24% |
| 2002 Q2 | 2.22 Million USD | 14.5% |
| 2002 Q1 | 1.94 Million USD | -19.15% |
| 2002 FY | 8.59 Million USD | -3.82% |
| 2002 Q4 | 2.08 Million USD | -9.96% |
| 2001 FY | 8.93 Million USD | 11.28% |
| 2001 Q1 | 1.97 Million USD | -18.49% |
| 2001 Q2 | 2.28 Million USD | 15.79% |
| 2001 Q3 | 2.28 Million USD | 0.01% |
| 2001 Q4 | 2.4 Million USD | 5.26% |
| 2000 Q4 | 2.41 Million USD | 31.08% |
| 2000 Q2 | 1.9 Million USD | 5.56% |
| 2000 Q1 | 1.8 Million USD | -28.0% |
| 2000 Q3 | 1.84 Million USD | -2.9% |
| 2000 FY | 8.03 Million USD | -7.66% |
| 1999 FY | 8.7 Million USD | -7.45% |
| 1999 Q1 | 2.2 Million USD | -12.0% |
| 1999 Q2 | 2.2 Million USD | 0.0% |
| 1999 Q3 | 1.8 Million USD | -18.18% |
| 1999 Q4 | 2.5 Million USD | 38.89% |
| 1998 Q1 | 2.3 Million USD | 0.0% |
| 1998 Q2 | 2.6 Million USD | 13.04% |
| 1998 Q4 | 2.5 Million USD | 19.05% |
| 1998 Q3 | 2.1 Million USD | -19.23% |
| 1998 FY | 9.4 Million USD | 2.17% |
| 1997 Q4 | 2.3 Million USD | 0.0% |
| 1997 FY | 9.2 Million USD | -3.16% |
| 1997 Q1 | 2.3 Million USD | -17.86% |
| 1997 Q2 | 2.3 Million USD | 0.0% |
| 1997 Q3 | 2.3 Million USD | 0.0% |
| 1996 FY | 9.5 Million USD | 3.26% |
| 1996 Q4 | 2.8 Million USD | 33.33% |
| 1996 Q1 | 2.3 Million USD | 0.0% |
| 1996 Q3 | 2.1 Million USD | -8.7% |
| 1996 Q2 | 2.3 Million USD | 0.0% |
| 1995 Q2 | 2.4 Million USD | 9.09% |
| 1995 FY | 9.2 Million USD | 10.84% |
| 1995 Q4 | 2.3 Million USD | 0.0% |
| 1995 Q3 | 2.3 Million USD | -4.17% |
| 1995 Q1 | 2.2 Million USD | 0.0% |
| 1994 Q4 | 2.2 Million USD | 15.79% |
| 1994 Q2 | 2.1 Million USD | 5.0% |
| 1994 Q3 | 1.9 Million USD | -9.52% |
| 1994 Q1 | 2 Million USD | -9.09% |
| 1994 FY | 8.3 Million USD | 3.75% |
| 1993 Q1 | 2 Million USD | 5.26% |
| 1993 FY | 8 Million USD | 2.56% |
| 1993 Q4 | 2.2 Million USD | 22.22% |
| 1993 Q3 | 1.8 Million USD | -5.26% |
| 1993 Q2 | 1.9 Million USD | -5.0% |
| 1992 Q3 | 1.7 Million USD | -10.53% |
| 1992 Q4 | 1.9 Million USD | 11.76% |
| 1992 Q1 | 2.2 Million USD | -15.38% |
| 1992 Q2 | 1.9 Million USD | -13.64% |
| 1992 FY | 7.8 Million USD | -25.0% |
| 1991 FY | 10.4 Million USD | 26.83% |
| 1991 Q1 | 2.6 Million USD | -64.38% |
| 1991 Q2 | 2.6 Million USD | 0.0% |
| 1991 Q3 | 2.6 Million USD | 0.0% |
| 1991 Q4 | 2.6 Million USD | 0.0% |
| 1990 Q1 | 300 Thousand USD | 0.0% |
| 1990 Q3 | 300 Thousand USD | 0.0% |
| 1990 Q2 | 300 Thousand USD | 0.0% |
| 1990 Q4 | 7.3 Million USD | 2333.33% |
| 1990 FY | 8.2 Million USD | 583.33% |
| 1989 Q3 | 300 Thousand USD | 0.0% |
| 1989 Q4 | 300 Thousand USD | 0.0% |
| 1989 FY | 1.2 Million USD | -14.29% |
| 1989 Q1 | 300 Thousand USD | 0.0% |
| 1989 Q2 | 300 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 55.096% |
| BrainsWay Ltd. | 31.78 Million USD | 82.964% |
| Cerus Corporation | 156.36 Million USD | 96.537% |
| Envoy Medical, Inc. | 316 Thousand USD | -1613.608% |
| electroCore, Inc. | 16.03 Million USD | 66.22% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -740.839% |
| IceCure Medical Ltd | 3.22 Million USD | -67.699% |
| Inogen, Inc. | 315.66 Million USD | 98.285% |
| OrthoPediatrics Corp. | 148.73 Million USD | 96.359% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -123.023% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -1383.566% |
| MaxCyte, Inc. | 41.28 Million USD | 86.885% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -177.345% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -4789.479% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.275% |
| PAVmed Inc | 2.45 Million USD | -120.84% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 75.954% |
| RxSight, Inc. | 89.07 Million USD | 93.921% |
| Sight Sciences, Inc. | 81.05 Million USD | 93.319% |
| SI-BONE, Inc. | 138.88 Million USD | 96.101% |
| TELA Bio, Inc. | 58.45 Million USD | 90.736% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 97.106% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 60.764% |
| Acutus Medical, Inc. | 7.16 Million USD | 24.414% |
| Talis Biomedical Corporation | 412 Thousand USD | -1214.32% |
| Spectral AI, Inc. | 18.05 Million USD | 70.01% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 45.331% |
| CVRx, Inc. | 39.29 Million USD | 86.22% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -458.993% |
| Bioventus Inc. | 512.34 Million USD | 98.943% |
| Venus Concept Inc. | 76.35 Million USD | 92.908% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 70.747% |
| LivaNova PLC | 1.15 Billion USD | 99.531% |
| 908 Devices Inc. | 50.22 Million USD | 89.219% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.877% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -6928.451% |
| NeuroPace, Inc. | 65.42 Million USD | 91.723% |
| LENSAR, Inc. | 42.16 Million USD | 87.157% |
| Apyx Medical Corporation | 52.34 Million USD | 89.656% |
| Cutera, Inc. | 212.36 Million USD | 97.45% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 83.767% |
| BioSig Technologies, Inc. | 18 Thousand USD | -29983.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 96.751% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 77.395% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.649% |
| Axonics, Inc. | 366.37 Million USD | 98.522% |
| Outset Medical, Inc. | 130.37 Million USD | 95.847% |
| IRIDEX Corporation | 51.86 Million USD | 89.56% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 96.024% |
| IRadimed Corporation | 65.56 Million USD | 91.741% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -360.459% |
| INVO Bioscience, Inc. | 3.02 Million USD | -79.271% |
| Telesis Bio, Inc. | 27.5 Million USD | 80.316% |
| Viemed Healthcare, Inc. | 183 Million USD | 97.041% |
| Varex Imaging Corporation | 811 Million USD | 99.332% |
| Quipt Home Medical Corp. | 221.74 Million USD | 97.558% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 92.115% |
| Dynatronics Corporation | 32.53 Million USD | 83.356% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 37.601% |
| Semler Scientific, Inc. | 68.18 Million USD | 92.058% |
| InMode Ltd. | 492.04 Million USD | 98.899% |
| Bruker Corporation | 2.96 Billion USD | 99.817% |
| Cytosorbents Corporation | 36.34 Million USD | 85.103% |
| DexCom, Inc. | 3.62 Billion USD | 99.851% |
| Align Technology, Inc. | 3.86 Billion USD | 99.86% |
| Viveve Medical, Inc. | 6.42 Million USD | 15.733% |
| ZimVie Inc. | 457.43 Million USD | 98.816% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 97.195% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -4789.479% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.276% |
| Profound Medical Corp. | 7.33 Million USD | 26.136% |
| Insulet Corporation | 1.69 Billion USD | 99.681% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 95.705% |
| iCAD, Inc. | 17.31 Million USD | 68.732% |
| Nuwellis, Inc. | 8.86 Million USD | 38.91% |
| Biotricity, Inc. | 12.06 Million USD | 55.112% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.901% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 12.732% |
| PAVmed Inc. | 2.45 Million USD | -120.84% |
| BIOLASE, Inc. | 49.16 Million USD | 88.986% |
| Beyond Air, Inc. | 1.15 Million USD | -367.213% |
| FONAR Corporation | 102.88 Million USD | 94.737% |
| AxoGen, Inc. | 159.01 Million USD | 96.595% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 98.027% |
| Inari Medical, Inc. | 493.63 Million USD | 98.903% |
| UFP Technologies, Inc. | 400.07 Million USD | 98.646% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -29012.903% |
| Tenon Medical, Inc. | 2.92 Million USD | -84.939% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 20.508% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.831% |
| Sintx Technologies, Inc. | 2.62 Million USD | -106.129% |
| NanoVibronix, Inc. | 2.28 Million USD | -137.188% |
| Quanterix Corporation | 122.36 Million USD | 95.575% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 77.812% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 97.3% |
| TransMedics Group, Inc. | 241.62 Million USD | 97.759% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 60.914% |
| NeuroMetrix, Inc. | 5.9 Million USD | 8.243% |
| Hyperfine, Inc. | 11.03 Million USD | 50.916% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 96.721% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 89.29% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 96.943% |